Trial Profile

Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 17 Jul 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Gliclazide (Primary) ; Perindopril/indapamide (Primary) ; Antihyperglycaemics
Indications Cardiovascular disorders; Diabetic angiopathies; Diabetic complications; Diabetic retinopathy; Type 2 diabetes mellitus
Focus Therapeutic Use
Acronyms ADVANCE-ON

Most Recent Events

13 Jul 2019 Results of post hoc analysis assessing benefits of using eGFR slopes for prediction of major clinical outcomes in diabetes using data from ADVANCE and ADVANCE-ON trials published in the Diabetologia
09 Apr 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
18 Jan 2014 United Kingdom Clinical Research Network reports planned end date as 1 April 2014.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com